-
1
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
Published 2025-02-01“…npj Breast Cancer…”
Get full text
Article -
2
Biological correlates associated with high-risk breast cancer patients identified using a computational method
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
3
Understanding metastasis mixed-treatment responses through genomic analyses
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
4
Co-targeting of metabolism using dietary and pharmacologic approaches reduces breast cancer metastatic burden
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
5
Racial discrimination among women seeking breast cancer care
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
6
Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study
Published 2025-02-01“…npj Breast Cancer…”
Get full text
Article -
7
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
8
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib
Published 2025-02-01“…npj Breast Cancer…”
Get full text
Article -
9
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
10
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article